LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.21 | 17.25 | 3131 | 4942 | 0.6335 | 0.8912 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.21 | 17.25 | 3061 | 4942 | 0.6193 | 0.8860 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.21 | 17.25 | 3314 | 4942 | 0.6705 | 0.9044 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.18 | 17.25 | 2928 | 5031 | 0.5819 | 0.8720 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.18 | 17.25 | 3325 | 5031 | 0.6608 | 0.9013 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.18 | 17.25 | 3175 | 5031 | 0.6310 | 0.8906 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.18 | 17.25 | 3491 | 5031 | 0.6938 | 0.9127 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.15 | 17.25 | 3105 | 5061 | 0.6135 | 0.8843 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.15 | 17.25 | 3493 | 5061 | 0.6902 | 0.9115 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.15 | 17.25 | 3351 | 5061 | 0.6621 | 0.9019 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.15 | 17.25 | 3686 | 5061 | 0.7283 | 0.9241 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.12 | 17.25 | 3357 | 5095 | 0.6589 | 0.9009 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.12 | 17.25 | 3670 | 5095 | 0.7203 | 0.9216 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.12 | 17.25 | 3060 | 5095 | 0.6006 | 0.8795 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.12 | 17.25 | 3884 | 5095 | 0.7623 | 0.9349 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.09 | 17.25 | 3403 | 5221 | 0.6518 | 0.8988 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.09 | 17.25 | 3829 | 5221 | 0.7334 | 0.9262 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.09 | 17.25 | 3531 | 5221 | 0.6763 | 0.9073 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.09 | 17.25 | 4066 | 5221 | 0.7788 | 0.9402 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.06 | 17.25 | 3647 | 5242 | 0.6956 | 0.9139 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.06 | 17.25 | 4044 | 5242 | 0.7714 | 0.9380 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.06 | 17.25 | 3669 | 5242 | 0.6998 | 0.9153 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.06 | 17.25 | 4271 | 5242 | 0.8147 | 0.9509 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.03 | 17.25 | 3539 | 5367 | 0.6594 | 0.9019 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.03 | 17.25 | 4280 | 5367 | 0.7975 | 0.9461 | MN20160310_N02 | L07 |